Interferon-γ Release Assays for Active Pulmonary Tuberculosis Diagnosis in Adults in Low- and Middle-Income Countries: Systematic Review and Meta-analysis
- 15 November 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 204 (suppl_4) , S1120-S1129
Abstract
The diagnostic value of interferon-γ release assays (IGRAs) for active tuberculosis in low- and middle-income countries is unclear. We searched multiple databases for studies published through May 2010 that evaluated the diagnostic performance of QuantiFERON-TB Gold In-Tube (QFT-GIT) and T-SPOT.TB (T-SPOT) among adults with suspected active pulmonary tuberculosis or patients with confirmed cases in low- and middle-income countries. We summarized test performance characteristics with use of forest plots, hierarchical summary receiver operating characteristic (HSROC) curves, and bivariate random effects models. Our search identified 789 citations, of which 27 observational studies (17 QFT-GIT and 10 T-SPOT) evaluating 590 human immunodeficiency virus (HIV)-uninfected and 844 HIV-infected individuals met inclusion criteria. Among HIV-infected patients, HSROC/bivariate pooled sensitivity estimates (highest quality data) were 76% (95% confidence interval [CI], 45%-92%) for T-SPOT and 60% (95% CI, 34%-82%) for QFT-GIT. HSROC/bivariate pooled specificity estimates were low for both IGRA platforms among all participants (T-SPOT, 61% [95% CI, 40%-79%]; QFT-GIT, 52% [95% CI, 41%-62%]) and among HIV-infected persons (T-SPOT, 52% [95% CI, 40%-63%]; QFT-GIT, 50% [95% CI, 35%-65%]). There was no consistent evidence that either IGRA was more sensitive than the tuberculin skin test for active tuberculosis diagnosis. In low- and middle-income countries, neither the tuberculin skin test nor IGRAs have value for active tuberculosis diagnosis in adults, especially in the context of HIV coinfection.Keywords
This publication has 54 references indexed in Scilit:
- Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithmsEuropean Respiratory Journal, 2011
- Interferon-Gamma Release Assays for the Diagnosis of Latent Tuberculosis Infection in HIV-Infected Individuals: A Systematic Review and Meta-AnalysisJAIDS Journal of Acquired Immune Deficiency Syndromes, 2011
- Evaluation of Quantitative IFN-γ Response for Risk Stratification of Active Tuberculosis SuspectsAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Diagnosis of Active Tuberculosis in China Using an In-House Gamma Interferon Enzyme-Linked Immunospot AssayClinical and Vaccine Immunology, 2009
- Interferon-γ release assays for the diagnosis of active tuberculosis: sensible or silly?European Respiratory Journal, 2009
- Enhancement of Diagnostic Efficiency by a Gamma Interferon Release Assay for Pulmonary TuberculosisClinical and Vaccine Immunology, 2008
- Grading quality of evidence and strength of recommendations for diagnostic tests and strategiesBMJ, 2008
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008
- Sensitivity of a Whole-Blood Interferon-Gamma Assay Among Patients with Pulmonary Tuberculosis and Variations in T-Cell Responses During Anti-Tuberculosis TreatmentInfection, 2007
- Sensitivity Analysis and Potential Uses of a Novel Gamma Interferon Release Assay for Diagnosis of TuberculosisJournal of Clinical Microbiology, 2006